People taking the highest dose (12 mg) lost an average of 71 pounds over 16 months, starting from an average weight of about 249 pounds
You cannot use a GLP-1 agonist if you do not fit into the criteria for the prescription and are just trying to shed a few pounds
Exenatide extended-release (Bydureon, Bydureon BCise) received FDA approval in 2012, offering once-weekly subcutaneous administration
While the small amounts found in multivitamins are typically safe, high-dose chromium supplements may intensify glucose-lowering effects when combined with GLP-1 medications
All trials analyzed the composite of 3 major adverse cardiovascular events (MACE), which included cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke, except the lixisenatide study that considered 4-point MACE, which also included hospitalization for heart failure (Table 1).5764 Although all the studies with arGLP-1 have demonstrated cardiovascular safety (noninferiority vs
Simple, inexpensive, and precise
